Shkreli’s Drug Companies Pay $40M To Settle Federal, State Antitrust Lawsuit
NEW YORK — Two drug companies controlled by Martin Shkreli on Dec. 7 agreed to pay $40 million to resolve civil antitrust allegations by the Federal Trade Commission and seven states...To view the full article, register now.
Already a subscriber? Click here to view full article